Page last updated: 2024-08-23

substance p and Chronic Primary Open Angle Glaucoma

substance p has been researched along with Chronic Primary Open Angle Glaucoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dada, T; Dwivedi, R; Gupta, V; Murugesan, V; Saini, M; Vivekanandhan, S	1

Other Studies

1 other study(ies) available for substance p and Chronic Primary Open Angle Glaucoma

Article	Year
Tear neuromediators in eyes on chronic topical antiglaucoma therapy with and without BAK preservatives. The British journal of ophthalmology, 2021, Volume: 105, Issue:1 Topics: Administration, Ophthalmic; Adolescent; Adult; Aged; Antihypertensive Agents; Benzalkonium Compounds; Calcitonin Gene-Related Peptide; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Eye Proteins; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Nerve Growth Factor; Neuropeptide Y; Neuropeptides; Ophthalmic Solutions; Preservatives, Pharmaceutical; Prospective Studies; Substance P; Tears; Vasoactive Intestinal Peptide; Young Adult	2021

Article

Year

Tear neuromediators in eyes on chronic topical antiglaucoma therapy with and without BAK preservatives.

The British journal of ophthalmology, 2021, Volume: 105, Issue:1

Topics: Administration, Ophthalmic; Adolescent; Adult; Aged; Antihypertensive Agents; Benzalkonium Compounds; Calcitonin Gene-Related Peptide; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Eye Proteins; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Nerve Growth Factor; Neuropeptide Y; Neuropeptides; Ophthalmic Solutions; Preservatives, Pharmaceutical; Prospective Studies; Substance P; Tears; Vasoactive Intestinal Peptide; Young Adult

2021